Peregrine Capital Management LLC Has $9.69 Million Position in Avantor, Inc. $AVTR

Peregrine Capital Management LLC cut its holdings in shares of Avantor, Inc. (NYSE:AVTR) by 24.6% during the second quarter, Holdings Channel reports. The fund owned 719,934 shares of the company’s stock after selling 235,202 shares during the quarter. Peregrine Capital Management LLC’s holdings in Avantor were worth $9,690,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also made changes to their positions in AVTR. Fifth Third Bancorp boosted its stake in Avantor by 1,741.4% in the 2nd quarter. Fifth Third Bancorp now owns 73,141 shares of the company’s stock valued at $984,000 after purchasing an additional 69,169 shares during the period. Swedbank AB grew its holdings in Avantor by 71.4% in the 2nd quarter. Swedbank AB now owns 102,514 shares of the company’s stock valued at $1,380,000 after buying an additional 42,700 shares in the last quarter. Stanley Capital Management LLC grew its holdings in Avantor by 42.9% in the 1st quarter. Stanley Capital Management LLC now owns 998,500 shares of the company’s stock valued at $16,186,000 after buying an additional 300,000 shares in the last quarter. Perpetual Ltd grew its holdings in Avantor by 3.5% in the 2nd quarter. Perpetual Ltd now owns 1,805,497 shares of the company’s stock valued at $24,302,000 after buying an additional 60,823 shares in the last quarter. Finally, US Bancorp DE grew its holdings in Avantor by 85.5% in the 1st quarter. US Bancorp DE now owns 11,135 shares of the company’s stock valued at $180,000 after buying an additional 5,133 shares in the last quarter. 95.08% of the stock is owned by institutional investors and hedge funds.

Avantor Price Performance

Shares of AVTR stock opened at $15.13 on Tuesday. The company has a quick ratio of 0.67, a current ratio of 0.98 and a debt-to-equity ratio of 0.48. Avantor, Inc. has a twelve month low of $10.82 and a twelve month high of $23.70. The company has a market cap of $10.31 billion, a P/E ratio of 15.28, a P/E/G ratio of 5.03 and a beta of 0.98. The business has a fifty day simple moving average of $13.37 and a 200 day simple moving average of $13.34.

Avantor (NYSE:AVTR) last announced its quarterly earnings data on Friday, August 1st. The company reported $0.24 earnings per share for the quarter, missing the consensus estimate of $0.25 by ($0.01). Avantor had a return on equity of 11.39% and a net margin of 10.31%.The business had revenue of $1.68 billion for the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter in the prior year, the company earned $0.25 earnings per share. Avantor’s quarterly revenue was down 1.1% compared to the same quarter last year. On average, sell-side analysts forecast that Avantor, Inc. will post 1.06 EPS for the current fiscal year.

Insider Buying and Selling at Avantor

In related news, CAO Steven W. Eck sold 3,476 shares of the company’s stock in a transaction on Tuesday, August 5th. The stock was sold at an average price of $11.39, for a total transaction of $39,591.64. Following the completion of the sale, the chief accounting officer directly owned 55,068 shares in the company, valued at $627,224.52. This represents a 5.94% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 1.20% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of brokerages have commented on AVTR. Morgan Stanley decreased their price objective on Avantor from $15.00 to $12.00 and set an “equal weight” rating on the stock in a report on Monday, August 4th. Royal Bank Of Canada cut their target price on Avantor from $20.00 to $17.00 and set an “outperform” rating for the company in a research report on Monday, August 4th. Jefferies Financial Group reiterated a “hold” rating on shares of Avantor in a research report on Friday, August 1st. Raymond James Financial upped their target price on Avantor from $14.00 to $16.00 and gave the company an “outperform” rating in a research report on Thursday, October 16th. Finally, Barclays upped their target price on Avantor from $13.00 to $15.00 and gave the company an “overweight” rating in a research report on Thursday, October 2nd. Seven analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $15.96.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.